STOCK TITAN

Helus Pharma: Venrock group reports 3.5% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Seven reporting persons, filing as a group, reported beneficial ownership equal to 2,688,175 Helus Pharma Inc. (HELP) common shares, or 3.5% of the class, as of September 30, 2026. The reported position consists of Common Warrants immediately exercisable for up to 561,560 shares held by Venrock Healthcare Capital Partners III, L.P., 56,183 held by VHCP Co-Investment Holdings III, LLC, and 2,070,432 held by Venrock Healthcare Capital Partners EG, L.P.

The reported percentage is based on 73,060,172 common shares outstanding as of September 1, 2026, giving effect to the warrants. The reporting persons reported shared voting and dispositive power over the position and no sole voting or dispositive power.

Beneficial ownership 2,688,175 common shares Reported by each of the seven reporting persons as of September 30, 2026
Percentage of class 3.5% Reported beneficial ownership as of September 30, 2026
Common shares outstanding 73,060,172 shares As of September 1, 2026; percentage calculation gives effect to warrants
Shares subject to Common Warrants held by Venrock Healthcare Capital Partners III, L.P. Up to 561,560 shares Immediately exercisable Common Warrants
Shares subject to Common Warrants held by VHCP Co-Investment Holdings III, LLC Up to 56,183 shares Immediately exercisable Common Warrants
Shares subject to Common Warrants held by Venrock Healthcare Capital Partners EG, L.P. Up to 2,070,432 shares Immediately exercisable Common Warrants
Common Warrants financial
"Common Warrants immediately exercisable for up to 561,560 common shares"
A common warrant is a tradable instrument that gives its holder the right to buy a company’s common shares at a fixed price within a set time period, similar to a coupon that can be redeemed later to purchase stock. Investors care because exercising warrants can boost potential gains if the stock rises, but it can also dilute existing shareholders by increasing the number of shares outstanding, which can lower per-share value.
beneficially owned regulatory
"Aggregate Amount Beneficially Owned by Each Reporting Person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power regulatory
"Shared Voting Power 2,688,175.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power 2,688,175.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HELP shares did the reporting persons beneficially own?

The seven reporting persons reported beneficial ownership equal to 2,688,175 common shares, or 3.5%, as of September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





423492107

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Venrock Healthcare Capital Partners III, L.P.
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
VHCP Co-Investment Holdings III, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management III, LLC, its Manager, By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
Venrock Healthcare Capital Partners EG, L.P.
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management EG, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
VHCP Management III, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
VHCP Management EG, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
Nimish Shah
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Attorney-in-fact
Date:11/16/2026
Bong Y. Koh
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Attorney-in-fact
Date:11/16/2026
Exhibit Information

Exhibit 24.1 Power of Attorney for Bong Y. Koh (incorporated by reference to Exhibit 24.1 to the Reporting Persons' Schedule 13G filed with the SEC on November 7, 2025). Exhibit 24.2 Power of Attorney for Nimish P. Shah (incorporated by reference to Exhibit 24.2 to the Reporting Persons' Schedule 13G filed with the SEC on November 7, 2025). Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Reporting Persons' Schedule 13G filed with the SEC on November 7, 2025).

Keep reading